Dashboard
Manage Tickers

THARTharimmune, Inc.

Nasdaq hillstreambio.com


$ 3.07 $ -0.31 (-9.9 %)    

Thursday, 20-Jun-2024 11:45:08 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 480.84 $ -1.29 (-0.27 %)
DIA $ 391.56 $ -0.73 (-0.19 %)
SPY $ 544.47 $ -0.73 (-0.13 %)
TLT $ 93.96 $ 0.00 (0 %)
GLD $ 214.79 $ -3.38 (-1.55 %)
$ 2.82
$ 3.05
$ 0.00 x 0
$ 0.00 x 0
$ 3.05 - $ 3.07
$ 2.75 - $ 163.09
53,229
na
2.21M
$ 0.12
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 02-23-2024 12-31-2023 10-K
3 11-07-2023 09-30-2023 10-Q
4 08-11-2023 06-30-2023 10-Q
5 05-22-2023 03-31-2023 10-Q
6 03-16-2023 12-31-2022 10-K
7 11-14-2022 09-30-2022 10-Q
8 08-11-2022 06-30-2022 10-Q
9 05-14-2022 03-31-2022 10-Q
10 04-01-2022 12-31-2021 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
Tharimmune Announces Securities Purchase A...
06/20/2024 12:16:27

Core News & Articles
Tharimmune Reports Type C Meeting With FDA...
06/17/2024 12:14:55

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
06/17/2024 12:07:49

Core News & Articles
Tharimmune Receives Notice From Nasdaq Con...
06/11/2024 20:19:00

why-skye-bioscience-shares-are-trading-lower-by-19-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Skye Bioscience Shares Are Trading Low...
06/10/2024 18:10:40

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
06/10/2024 16:31:08

why-tharimmune-thar-shares-are-getting-hammered
Why Tharimmune (THAR) Shares Are Getting H...
06/10/2024 16:04:41

Tharimmune shares are trading lower by 30% during Monday's session. The company late Friday announced it had entered into a...

Core News & Articles
Reported Friday, "Tharimmune Enters ATM Ag...
06/10/2024 16:03:20

- Form 8-K

Core News & Articles
Trading Halt: Halted at 7:50:00 p.m. ET - ...
05/24/2024 23:50:04

why-tharimmune-thar-shares-are-moving
Why Tharimmune (THAR) Shares Are Moving
05/22/2024 16:26:51

Tharimmune shares are trading lower by 16.4% during Wednesday's session. The company announced a 1-for-15 reverse stock split.

Core News & Articles
Tharimmune Earlier Announced A 1-For-15 Re...
05/22/2024 15:13:58

Tharimmune, Inc. (NASDAQ:THAR) ("Tharimmune" or the "Company"), a clinical-stage biotechnology company developi...

12-health-care-stocks-moving-in-wednesdays-pre-market-session
12 Health Care Stocks Moving In Wednesday'...
05/22/2024 12:06:41

Core News & Articles
Tharimmune Announced An Option Agreement F...
04/23/2024 11:35:58

Core News & Articles
Tharimmune Forms Scientific Advisory Board...
04/15/2024 12:35:51

Group includes leading experts in multiple disciplines including immunology, liver diseases, protein engineering, antibody drug...

tharimmunes-oral-under-the-cheek-candidate-at-par-with-fda-approved-injectable-with-potential-for-chronic-liver-disease
Tharimmune's Oral 'Under The Cheek' Candid...
02/20/2024 21:10:43

Tharimmune achieves success in Phase 1 trial for TH104, a buccal film with nalmefene. Encouraging safety profile and potential ...

Core News & Articles
Tharimmune Announces Results In Phase 1 Cl...
02/20/2024 13:08:00

Positive safety/tolerability profile achieved with TH104 showing self-resolving, mild side effect profile aligned with previous...

12-health-care-stocks-moving-in-tuesdays-pre-market-session
12 Health Care Stocks Moving In Tuesday's ...
02/20/2024 13:05:50

Core News & Articles
Tharimmune Announces Dosing Of First Patie...
02/05/2024 13:35:15

Phase 1 clinical trial dosing of first patient complete; primary objective to assess safety/tolerability and absolute bioavaila...

Core News & Articles
Tharimmune Has Initiated A Phase 1 Trial W...
01/29/2024 13:06:44

Planning well underway for Phase 2 of TH104 in primary biliary cholangitis (PBC) patients suffering from moderate-to-severe c...

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
01/25/2024 21:31:04

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)